EPISODE · Jul 3, 2025 · 24 MIN
Ocular Therapeutix’ bold vision to redefine retinal disease treatment
Pravin Dugel, CEO of Ocular Therapeutix provides insights into existing treatments and future product candidates for retinal diseases, underlining the unique challenges, opportunities and innovations in this evolving landscape. www.ocutx.comPravin U. Dugel, MD Biography
Embed this episode
NOW PLAYING
Ocular Therapeutix’ bold vision to redefine retinal disease treatment
0:00
24:52
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Pathfinders in Biopharma?
This episode is 24 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on July 3, 2025.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!